Form NPORT-P GUGGENHEIM STRATEGIC For: Feb 27
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crescent Biopharma prices $125M public offering of shares and warrants
- DXL board rejects Zodiac's $0.84 per share unsolicited tender offer
- Guggenheim Reiterates Neutral Rating on Warner Brothers Discovery (WBD)
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
